PharmacoFore Raises $10M in Funding from Founders Fund

PharmacoFore, a San Carlos, CA-based biopharmaceutical company, has raised $10m in equity funding from Founders Fund.

The company intends to use the new capital to advance its pipeline (read here) to regulatory approval and commercialization.

Led by CEO Wes Sterman, PharmacoFore uses innovative synthetic organic chemistry to create novel medicines for treating a variety of conditions related to the central and peripheral nervous systems.

In conjunction with the funding, Founders Fund partner Ken Howery has joined the company’s Board of Directors.



Join the discussion